Andrew Hudson

Andrew Hudson has extensive work experience in the field of chemistry. Starting in 2000, they served as a Postdoctoral Research Fellow at Wayne State University. Andrew then joined Ligand Pharmaceuticals in 2002, where they worked as a Research Investigator and Medicinal Chemist until 2010.

In 2011, Hudson joined GNF as a Research Investigator before transitioning to Dart NeuroScience LLC later that year. At Dart NeuroScience, they held various roles, including Scientist III and Scientist IV in Medicinal Chemistry, as well as Associate Manager Medicinal Chemistry.

In 2018, Hudson moved to Metacrine, Inc. as an Associate Director of Chemistry. Andrew later became the Director of Chemistry in 2021 before joining RayzeBio as the Senior Director of Chemistry in the same year.

Throughout their career, Hudson has gained extensive expertise and knowledge in the field of chemistry, specifically in medicinal chemistry.

Andrew Hudson completed their Bachelor of Science degree in Chemistry at Durham University from 1993 to 1996. Andrew further pursued their academic journey by obtaining a PhD in Synthetic Organic Chemistry from the University of Bristol, where they studied from 1996 to 2000.